Doxorubicin immunoconjugates containing bivalent, lysosomally-Cleavable dipeptide linkages
- 19 April 2002
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 12 (11) , 1529-1532
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Receptor-mediated and enzyme-dependent targeting of cytotoxic anticancer drugsPharmacology & Therapeutics, 1999
- Monoclonal Antibody Conjugates of Doxorubicin Prepared with Branched Linkers: A Novel Method for Increasing the Potency of Doxorubicin ImmunoconjugatesBioconjugate Chemistry, 1999
- Cathepsin B-sensitive dipeptide prodrugs. 1. A model study of structural requirements for efficient release of doxorubicinBioorganic & Medicinal Chemistry Letters, 1998
- Monomethoxytrityl (MMT) as a versatile amino protecting group for complex prodrugs of anticancer compounds sensitive to strong acids, bases and nucleophilesTetrahedron Letters, 1997
- (6-Maleimidocaproyl)hydrazone of doxorubicin. A new derivative for the preparation of immunoconjugates of doxorubicinBioconjugate Chemistry, 1993
- Cure of Xenografted Human Carcinomas by BR96-Doxorubicin ImmunoconjugatesScience, 1993
- A novel connector linkage applicable in prodrug designJournal of Medicinal Chemistry, 1981
- The specificity of uptake of model immune complexes and other protein aggregates by the murine reticuloendothelial system.The Journal of Immunology, 1980
- Alkylation of Serine at the Active Site of TrypsinHoppe-Seyler´s Zeitschrift Für Physiologische Chemie, 1968